Neurobiology of glutamatergic abnormalities in schizophrenia

Clinical Neuroscience Research

Volumn 3, Issue 1-2, 2003, Pages 67-76

  Haroutunian, Vahram ^a   Dracheva, Stella ^a   Davis, Kenneth L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dorsolateral prefrontal cortex; Glutamate; mRNA; Postmortem; Receptors; Schizophrenia

Indexed keywords

AMPA RECEPTOR; DNA; GLUTAMATE DECARBOXYLASE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLUTAMINASE; GLUTAMINE; IONOTROPIC RECEPTOR; KAINIC ACID RECEPTOR; KETAMINE; MEMBRANE PROTEIN; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; PHOSPHATE; RECEPTOR SUBUNIT;

BEHAVIOR; CLINICAL STUDY; DNA MICROARRAY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC ANALYSIS; HUMAN; NEUROBIOLOGY; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; RECEPTOR BINDING; REVIEW; SCHIZOPHRENIA; SYMPTOM;

EID: 0042029752     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1566-2772(03)00020-3     Document Type: Review

References (171)

1. Goff D.C. Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia Am J Psychiatry 158 2001 1367-1377
2. Meador-Woodruff J.H. Healy D.J. Glutamate receptor expression in schizophrenic brain Brain Res Rev 31 2000 288-294
3. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia Brain Res Rev 31 2000 251-269
4. Javitt D. Zukin S. Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 148 1991 1301-1308
5. Krystal J.H. Karper L.P. Seibyl J.P. et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive and neuroendocrine responses Arch Gen Psychiatry 51 1994 199-214
6. Krystal J.H. D'Souza D.C. Petrakis I.L. et al. NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders Harv Rev Psychiatry 7 1999 125-143
7. Krystal J.H. Moghaddam B. Breier A. Goldman-Rakic P.S. McElvey J. Glutamate, dopamine, the frontal cortex, and schizophrenia Biol Psychiatry 43 1998 60S
8. Anand A. Charney D.S. Oren D.A. et al. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-d-aspartate receptor antagonists Arch Gen Psychiatry 57 2000 270-276
9. Halberstadt A.L. The phencyclidine-glutamate model of schizophrenia Clin Neuropharmacol 18 1995 237-249
10. Lahti A.C. Holcomb H.H. Medoff D.R. Tamminga C.A. Ketamine activates psychosis and alters limbic blood flow in schizophrenia Neuroreport 6 1995 869-872
11. Lahti A.C. Koffel B. LaPorte D. Tamminga C.A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia Neuropsychopharmacology 13 1995 9-19
12. Itil T. Keskiner A. Kiremitci N. Holden J.M. Effect of phencyclidine in chronic schizophrenics Can Psychiatr Assoc J 12 1967 209-212
13. Olney J.W. Farber N.B. Glutamate receptor dysfunction and schizophrenia Arch Gen Psychiatry 52 1995 998-1007
14. Carlsson A. Waters N. Carlsson M.L. Neurotransmitter interactions in schizophrenia - therapeutic implications Biol Psychiatry 46 1999 1388-1395
15. Carlsson A. Hansson L.O. Waters N. Carlsson M.L. A glutamatergic deficiency model of schizophrenia Br J Psychiatry Suppl 1999 2-6
16. Harrison P.J. The neuropathology of schizophrenia.A critical review of the data and their interpretation Brain 122 1999 593-624
17. Nishikawa T. Takashima M. Toru M. Increased [3H] kainic acid binding in the prefrontal cortex in schizophrenia Neurosci Lett 40 1983 245-250
18. Toru M. Watanabe S. Shibuya H. et-al. Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients Acta Psychiatr Scand 78 1988 121-137
19. Kornhuber J. Mack Burkhardt F. Riederer P. et al. [3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients J Neural Transm 77 1989 231-236
20. Byerley W. Bailey M.E. Hicks A.A. et al. Schizophrenia and GABAA receptor subunit genes Psychiatr Genet 5 1995 23-29
21. Grimwood S. Slater P. Deakin J.F. Hutson P.H. NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia Neuroreport 10 1999 461-465
22. Simpson M.D. Slater P. Deakin J.F. Comparison of glutamate and gamma-aminobutyric acid uptake binding sites in frontal and temporal lobes in schizophrenia Biol Psychiatry 44 1998 423-427
23. Longson D. Deakin J.F. Benes F.M. Increased density of entorhinal glutamate-immunoreactive vertical fibers in schizophrenia J Neural Transm 103 1996 503-507
24. Deakin J.F. Slater P. Simpson M.D. et al. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia J Neurochem 52 1989 1781-1786
25. Meador-Woodruff J.H. Haroutunian V. Davis K.L. Watson S.J. NMDA receptor dysregulation in schizophrenic prefrontal cortex Biol Psychiatry 43 1998 83S
26. Akbarian S. Sucher N. Bradley D. et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics J Neurosci 16 1996 19-30
27. Korpi E.R. Kleinman J.E. Goodman S.I. Wyatt R.J. Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients Psychiatry Res 22 1987 291-301
28. Sherman A.D. Hegwood T.S. Baruah S. Waziri R. Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics Biol Psychiatry 30 1991 1191-1198
29. Gao X.M. Sakai K. Roberts R.C. Conley R.R. Dean B. Tamminga C.A. Ionotropic glutamate receptors and expression of N-methyl-d-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia Am J Psychiatry 157 2000 1141-1149
30. Simpson M.D.C. Slater P. Royston M.C. Deakin J.F.W. Alterations in phencyclidine and sigma binding sites in schizophrenia brains: effects of disease process and neuroleptic medication Schizophr Res 6 1992 41-48
31. Dracheva S. Marras S.A.E. Kramer F.R. Davis K.L. Haroutunian V. N-methyl-d-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia Am J Psychiatry 158 2001 1400-1410
32. Breier A. Cognitive deficit in schizophrenia and its neurochemical basis Br J Psychiatry Suppl 1999 16-18
33. Haroutunian V. Santucci A.C. Pharmacological animal models of dementia In: Charney D.S. Nestler E.J. Bunney B.S. (Eds.) Neurobiology of mental illness 1999 669-678 Oxford University Press New York, NY
34. Olney J.W. Newcomer J.W. Farber N.B. NMDA receptor hypofunction model of schizophrenia J Psychiatr Res 33 1999 523-533
35. Anegawa N.J. Guttmann R.P. Grant E.R. Anand R. Lindstrom J. Lynch D.R. N-methyl-d-aspartate receptor mediated toxicity in nonneuronal cell lines: characterization using fluorescent measures of cell viability and reactive oxygen species production Brain Res Mol Brain Res 77 2000 163-175
36. Nudmamud S. Reynolds G.P. Increased density of glutamate/ N-methyl-d-aspartate receptors in superior temporal cortex in schizophrenia Neurosci Lett 304 2001 9-12
37. Noga J.T. Hyde T.M. Bachus S.E. Herman M.M. Kleinman J.E. AMPA receptor binding in the dorsolateral prefrontal cortex of schizophrenics and controls Schizophr Res 48 2001 361-363
38. Le Corre S. Harper C.G. Lopez P. Ward P. Catts S. Increased levels of expression of an NMDARI splice variant in the superior temporal gyrus in schizophrenia Neuroreport 11 2000 983-986
39. Gluck M.R. Thomas R.G. Davis K.L. Haroutunian V. Increased phosphate-activated glutaminase and glutamic acid decarboxylase activities in dorsolateral prefrontal cortex of aged schizophrenics: altered glutamate and GABA metabolism in schizophrenia AJP 159 2002 1165-1173
40. Dracheva S. Gluck M.R. Elhakem S.L. Siever L. Davis K.L. Haroutunian V. Glutamate synthesis and NMDA receptor and PSD-95 expression in DLPFC and occipital cortices of schizophrenics Soc Neurosci Abst 335 2001 5
41. Hollmann M. Heinemann S. Cloned glutamate receptors In: Cowan W. Shooter E. Stevens C. Thompson R. (Eds.) Annual review of neuroscience 1994 31-108 Annual Reviews Inc. Palo Alto
42. Chittajallu R. Braithwaite S.P. Clarke V.R. Henley J.M. Kainate receptors: subunits, synaptic localization and function Trends Pharmacol Sci 20 1999 26-35
43. Frerking M. Nicoll R.A. Synaptic kainate receptors Curr Opin Neurobiol 10 2000 342-351
44. Conti F. Minelli A. DeBiasi S. Melone M. Neuronal and glial localization of NMDA receptors in the cerebral cortex Mol Neurobiol 14 1997 1-18
45. Huntley G.W. Vickers J.C. Morrison J.H. Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organizational features related to cortical circuitry, function and disease Trends Neurosci 17 1994 536-543
46. He Y. Janssen W.G. Morrison J.H. Synaptic coexistence of AMPA and NMDA receptors in the rat hippocampus: a postembedding immunogold study J Neurosci Res 54 1998 444-449
47. Keinanen K. Wisden W. Sommer B. et al. A family of AMPA-selective glutamate receptors Science 249 1990 556-560
48. Boulter J. Hollmann M. O'Shea-Greenfield A. et al. Molecular cloning and functional expression of glutamate receptor subunit genes Science 249 1990 1033-1037
49. Rose C.R. Konnerth A. Self-regulating synapses Nature 405 2000 413-415
50. Luscher C. Xia H. Beattie E.C. et al. Role of AMPA receptor cycling in synaptic transmission and plasticity Neuron 24 1999 649-658
51. Noel J. Ralph G.S. Pickard L. et al. Surface expression of AMPA receptors in hippocampal neurons is regulated by an NSF-dependent mechanism Neuron 23 1999 365-376
52. Song I. Kamboj S. Xia J. Dong H. Liao D. Huganir R.L. Interaction of the N-ethylmaleimide-sensitive factor with AMPA receptors Neuron 21 1998 393-400
53. Zhu J.J. Esteban J.A. Hayashi Y. Malinow R. Postnatal synaptic potentiation: delivery of GluR4-containing AMPA receptors by spontaneous activity Nat Neurosci 3 2000 1098-1106
54. Bettler B. Boulter J. Hermans-Borgmeyer I. et al. Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development Neuron 5 1990 583-595
55. Egebjerg J. Bettler B. Hermans-Borgmeyer I. Heinemann S. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA Nature 351 1991 745-748
56. Werner P. Voigt M. Keinanen K. Wisden W. Seeburg P.H. Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells Nature 351 1991 742-744
57. Bettler B. Egebjerg J. Sharma G. et al. Cloning of a putative glutamate receptor: a low affinity kainate-binding subunit Neuron 8 1992 257-265
58. Herb A. Burnashev N. Werner P. Sakmann B. Wisden W. Seeburg P.H. The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits Neuron 8 1992 775-785
59. Lerma J. Paternain A.V. Rodriguez-Moreno A. Lopez-Garcia J.C. Molecular physiology of kainate receptors Physiol Rev 81 2001 971-998
60. Lerma J. Kainate receptors keep the excitement high Trends Neurosci 24 2001 139-140
61. Moriyoshi K. Masu M. Ishii T. Shigemoto R. Mizuno N. Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor Nature 354 1991 31-37
62. Meguro H. Mori H. Araki K. et-al. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs Nature 357 1992 70-74
63. Monyer H. Sprengel R. Schoepfer R. et al. Heteromeric NMDA receptors: molecular and functional distinction of subtypes Science 256 1992 1217-1221
64. Kutsuwada T. Kashiwabuchi N. Mori H. et al. Molecular diversity of the NMDA receptor channel Nature 358 1992 36-41
65. Ishii T. Moriyoshi K. Sugihara H. et al. Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits J Biol Chem 268 1993 2836-2843
66. Ciabarra A.M. Sullivan J.M. Gahn L.G. Pecht G. Heinemann S. Sevarino K.A. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family J Neurosci 15 1995 6498-6508
67. Sucher N.J. Akbarian S. Chi C.L. et-al. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain J Neurosci 15 1995 6509-6520
68. Nishi M. Hinds H. Lu H.P. Kawata M. Hayashi Y. Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner J Neurosci 21 2001 RC185
69. Rigby M. Le Bourdelles B. Heavens R.P. et al. The messenger RNAs for the N-methyl-d-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain Neuroscience 73 1996 429-447
70. Johnson J.W. Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons Nature 325 1987 529-531
71. Mothet J.P. Parent A.T. Wolosker H. et al. d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor Proc Natl Acad Sci USA 97 2000 4926-4931
72. Nowak L. Bregestovski P. Ascher P. Herbet A. Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurons Nature 307 1984 462-465
73. Mayer M.L. Westbrook G.L. Guthrie P.B. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurons Nature 309 1984 261-263
74. Seeburg P.H. The TINS/TiPS lecture. The molecular biology of mammalian glutamate receptor channels Trends Neurosci 16 1993 359-365
75. Durand G.M. Kovalchuk Y. Konnerth A. Long-term potentiation and functional synapse induction in developing hippocampus Nature 381 1996 71-75
76. Isaac J.T. Crair M.C. Nicoll R.A. Malenka R.C. Silent synapses during development of thalamocortical inputs Neuron 18 1997 269-280
77. Liao D. Zhang X. O'Brien R. Ehlers M.D. Huganir R.L. Regulation of morphological postsynaptic silent synapses in developing hippocampal neurons Nat Neurosci 2 1999 37-43
78. Takumi Y. Ramirez-Leon V. Laake P. Rinvik E. Ottersen O.P. Different modes of expression of AMPA and NMDA receptors in hippocampal synapses Nat Neurosci 2 1999 618-624
79. Feldman D.E. Knudsen E.I. Experience-dependent plasticity and the maturation of glutamatergic synapses Neuron 20 1998 1067-1071
80. Shi S. Hayashi Y. Esteban J.A. Malinow R. Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons Cell 105 2001 331-343
81. Wenthold R.J. Yokotani N. Doi K. Wada K. Immunochemical characterization of the non-NMDA glutamate receptor using subunit-specific antibodies. Evidence for a hetero-oligomeric structure in rat brain J Biol Chem 267 1992 501-507
82. Brose N. Huntley G.W. Stern-Bach Y. Sharma G. Morrison J.H. Heinemann S.F. Differential assembly of coexpressed glutamate receptor subunits in neurons of rat cerebral cortex J Biol Chem 269 1994 16780-16784
83. Puchalski R.B. Louis J.C. Brose N. et al. Selective RNA editing and subunit assembly of native glutamate receptors Neuron 13 1994 131-147
84. Kohler M. Burnashev N. Sakmann B. Seeburg P.H. Determinants of Ca2+ permeability in both TM1 and TM2 of high affinity kainate receptor channels: diversity by RNA editing Neuron 10 1993 491-500
85. Bockaert J. Pin J.P. Molecular tinkering of G protein-coupled receptors: an evolutionary success EMBO J 18 1999 1723-1729
86. De Blasi A. Conn P.J. Pin J. Nicoletti F. Molecular determinants of metabotropic glutamate receptor signaling Trends Pharmacol Sci 22 2001 114-120
87. O'Hara P.J. Sheppard P.O. Thogersen H. et-al. The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins Neuron 11 1993 41-52
88. Kunishima N. Shimada Y. Tsuji Y. et al. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor Nature 407 2000 971-977
89. Boudin H. Doan A. Xia J. et al. Presynaptic clustering of mGluR7a requires the PICK1 PDZ domain binding site Neuron 28 2000 485-497
90. Bordi F. Ugolini A. Group I metabotropic glutamate receptors: implications for brain diseases Prog Neurobiol 59 1999 55-79
91. Schoepp D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system J Pharmacol Exp Ther 299 2001 12-20
92. Salt T.E. Eaton S.A. Functions of ionotropic and metabotropic glutamate receptors in sensory transmission in the mammalian thalamus Prog Neurobiol 48 1996 55-72
93. Eaton S.A. Salt T.E. Role of N-methyl-d-aspartate and metabotropic glutamate receptors in corticothalamic excitatory postsynaptic potentials in vivo Neuroscience 73 1996 1-5
94. Richardson-Burns S.M. Haroutunian V. Davis K.L. Watson S.J. Meador-Woodruff J.H. Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus Biol Psychiatry 47 2000 22-28
95. Dracheva S. Marras S.A.E. Kramer F.R. Davis K.L. Haroutunian V. NMDA receptor expression in DLPFC of schizophrenics Soc Neurosci Abst 112 2000 8
96. Ibrahim H.M. Hogg A.J. Healy D.J. et al. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei of elderly schizophrenics Am J Psychiatry 157 2000 1811-1823
97. Smith R.E. Haroutunian V. Davis K.L. Meador-Woodruff J.H. Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia Am J Psychiatry 158 2001 1393-1399
98. Cahlon O. Haroutunian V. Davis K.L. Watson S.J. Meador-Woodruff J.H. Kainate receptor expression in postmortem schizophrenic brain Biol Psychiatry 43 1998 121S
99. Healy D.J. Haroutunian V. Powchik P. et al. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics Neuropsychopharmacology 19 1998 278-286
100. Meador-Woodruff J.H. Healy D.J. Haroutunian V. et al. Ionotropic glutamate receptors in schizophrenic brain Society for Biol Psychiatry 41 1997 66S
101. Crook J.M. Akil M. Law B.C. Hyde T.M. Kleinman J.E. Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects Mol Psychiatry 7 2002 157-164
102. Moghaddam B. Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 281 1998 1349-1352
103. Moghaddam B. Adams B. Verma A. Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J Neurosci 17 1997 2921-2927
104. Kennedy M.B. The postsynaptic density at glutamatergic synapses Trends Neurosci 20 1997 264-268
105. Ehlers M.D. Synapse structure: glutamate receptors connected by the shanks Curr Biol 9 1999 R848-R850
106. Kornau H.C. Schenker L.T. Kennedy M.B. Seeburg P.H. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95 Science 269 1995 1737-1740
107. Christopherson K.S. Hillier B.J. Lim W.A. Bredt D.S. PSD-95 assembles a ternary complex with the N-methyl-d-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain J Biol Chem 274 1999 27467-27473
108. Cattabeni F. Gardoni F. Di Luca M. Pathophysiological implications of the structural organization of the excitatory synapse Eur J Pharmacol 375 1999 339-347
109. Sheng M. Pak D.T. Glutamate receptor anchoring proteins and the molecular organization of excitatory synapses Ann NY Acad Sci 868 1999 483-493
110. Okabe S. Kim H.D. Miwa A. Kuriu T. Okado H. Continual remodeling of postsynaptic density and its regulation by synaptic activity Nat Neurosci 2 1999 804-811
111. Aoki C. Bredt D.S. Fenstemaker S. Lubin M. The subcellular distribution of nitric oxide synthase relative to the NR1 subunit of NMDA receptors in the cerebral cortex Prog Brain Res 118 1998 83-97
112. Hunt C.A. Schenker L.J. Kennedy M.B. PSD-95 is associated with the postsynaptic density and not with the presynaptic membrane at forebrain synapses J Neurosci 16 1996 1380-1388
113. Sattler R. Xiong Z. Lu W.Y. Hafner M. MacDonald J.F. Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein Science 284 1999 1845-1848
114. Migaud M. Charlesworth P. Dempster M. et al. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein Nature 396 1998 433-439 [see comments]
115. Lau L.F. Mammen A. Ehlers M.D. et al. Interaction of the N-methyl-d-aspartate receptor complex with a novel synapse-associated protein, SAP102 J Biol Chem 271 1996 21622-21628
116. Niethammer M. Kim E. Sheng M. Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases J Neurosci 16 1996 2157-2163
117. Dong H. O'Brien R.J. Fung E.T. Lanahan A.A. Worley P.F. Huganir R.L. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors Nature 386 1997 279-284
118. Srivastava S. Osten P. Vilim F.S. et al. Novel anchorage of GluR2/3 to the postsynaptic density by the AMPA receptor-binding protein ABP Neuron 21 1998 581-591
119. Dong H. Zhang P. Song I. Petralia R.S. Liao D. Huganir R.L. Characterization of the glutamate receptor-interacting proteins GRIP1 and GRIP2 J Neurosci 19 1999 6930-6941
120. Xia J. Zhang X. Staudinger J. Huganir R.L. Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1 Neuron 22 1999 179-187
121. Dev K.K. Nishimune A. Henley J.M. Nakanishi S. The protein kinase C alpha binding protein PICK1 interacts with short but not long form alternative splice variants of AMPA receptor subunits Neuropharmacology 38 1999 635-644
122. Torres R. Firestein B.L. Dong H. et al. PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands Neuron 21 1998 1453-1463
123. Bruckner K. Pablo L.J. Scheiffele P. Herb A. Seeburg P.H. Klein R. EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains Neuron 22 1999 511-524
124. Ye B. Liao D. Zhang X. Zhang P. Dong H. Huganir R.L. GRASP-1: a neuronal RasGEF associated with the AMPA receptor/GRIP complex Neuron 26 2000 603-617
125. Tanaka K. Watase K. Manabe T. et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1 Science 276 1997 1699-1702
126. Rothstein J.D. Dykes-Hoberg M. Pardo C.A. et-al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate Neuron 16 1996 675-686
127. Sims K.D. Robinson M.B. Expression patterns and regulation of glutamate transporters in the developing and adult nervous system Crit Rev Neurobiol 13 1999 169-197
128. Nakayama T. Kawakami H. Tanaka K. Nakamura S. Expression of three glutamate transporter subtype mRNAs in human brain regions and peripheral tissues Brain Res Mol Brain Res 36 1996 189-192
129. Fairman W.A. Vandenberg R.J. Arriza J.L. Kavanaugh M.P. Amara S.G. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel Nature 375 1995 599-603
130. Wadiche J.I. Arriza J.L. Amara S.G. Kavanaugh M.P. Kinetics of a human glutamate transporter Neuron 14 1995 1019-1027
131. Arriza J.L. Eliasof S. Kavanaugh M.P. Amara S.G. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance Proc Natl Acad Sci USA 94 1997 4155-4160
132. Chaudhry F.A. Lehre K.P. van Lookeren C.M. Ottersen O.P. Danbolt N.C. Storm-Mathisen J. Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry Neuron 15 1995 711-720
133. Lehre K.P. Levy L.M. Ottersen O.P. Storm-Mathisen J. Danbolt N.C. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations J Neurosci 15 1995 1835-1853
134. Shibata T. Watanabe M. Tanaka K. Wada K. Inoue Y. Dynamic changes in expression of glutamate transporter mRNAs in developing brain Neuroreport 7 1996 705-709
135. Schmitt A. Asan E. Puschel B. Jons T. Kugler P. Expression of the glutamate transporter GLT1 in neural cells of the rat central nervous system: non-radioactive in situ hybridization and comparative immunocytochemistry Neuroscience 71 1996 989-1004
136. Valjakka A. Riekkinen P. Sirvio J. et-al. The effects of dorsal noradrenergic bundle lesions on spatial learning, locomotor activity, and reaction to novelty Behav Neural Biol 54 1990 323-329
137. Schmitt A. Asan E. Puschel B. Kugler P. Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: nonradioactive in situ hybridization and comparative immunocytochemistry J Neurosci 17 1997 1-10
138. Torp R. Hoover F. Danbolt N.C. Storm-Mathisen J. Ottersen O.P. Differential distribution of the glutamate transporters GLT1 and rEAAC1 in rat cerebral cortex and thalamus: an in situ hybridization analysis Anat Embryol (Berl) 195 1997 317-326
139. Hediger M.A. Kanai Y. You G. Nussberger S. Mammalian ion-coupled solute transporters J Physiol (Lond) 482 1995 7S-17S
140. Kanai Y. Bhide P.G. DiFiglia M. Hediger M.A. Neuronal high-affinity glutamate transport in the rat central nervous system Neuroreport 6 1995 2357-2362
141. Kanai Y. Hediger M.A. Primary structure and functional characterization of a high-affinity glutamate transporter Nature 360 1992 467-471 [see comments]
142. Rothstein J.D. Martin L. Levey A.I. et al. Localization of neuronal and glial glutamate transporters Neuron 13 1994 713-725
143. Yamada K. Watanabe M. Shibata T. Tanaka K. Wada K. Inoue Y. EAAT4 is a post-synaptic glutamate transporter at Purkinje cell synapses Neuroreport 7 1996 2013-2017
144. Furuta A. Martin L.J. Lin C.L. Dykes-Hoberg M. Rothstein J.D. Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4 Neuroscience 81 1997 1031-1042
145. Nagao S. Kwak S. Kanazawa I. EAAT4, a glutamate transporter with properties of a chloride channel, is predominantly localized in Purkinje cell dendrites, and forms parasagittal compartments in rat cerebellum Neuroscience 78 1997 929-933
146. Tanaka J. Ichikawa R. Watanabe M. Tanaka K. Inoue Y. Extra-junctional localization of glutamate transporter EAAT4 at excitatory Purkinje cell synapses Neuroreport 8 1997 2461-2464
147. He Y. Janssen W.G. Rothstein J.D. Morrison J.H. Differential synaptic localization of the glutamate transporter EAAC1 and glutamate receptor subunit GluR2 in the rat hippocampus J Comp Neurol 418 2000 255-269
148. Appel S.H. Excitotoxic neuronal cell death in amyotrophic lateral sclerosis Trends Neurosci 16 1993 3-5
149. Portera-Cailliau C. Hedreen J.C. Price D.L. Koliatsos V.E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models J Neurosci 15 1995 3775-3787
150. Lesch K.P. Heils A. Riederer P. The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes J Mol Med 74 1996 365-378
151. Kanai Y. Family of neutral and acidic amino acid transporters: molecular biology, physiology and medical implications Curr Opin Cell Biol 9 1997 565-572
152. Ohnuma T. Augood S.J. Arai H. McKenna P.J. Emson P.C. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia Brain Res Mol Brain Res 56 1998 207-217
153. Meador-Woodruff J.H. Davis K.L. Haroutunian V. Abnormal kainate receptor expression in prefrontal cortex in schizophrenia Neuropsychopharmacology 24 2001 545-552
154. Smith R.E. Haroutunian V. Davis K.L. Meador-Woodruff J.H. Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia Neuroreport 12 2001 2885-2887
155. Hakak Y. Wlaker J.R. Li C. et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia Proc Natl Acad Sci USA 98 2001 4746-4751
156. Davidson M. Harvey P.D. Powchik P. et al. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients Am J Psychiatry 152 1995 197-207
157. Harvey P.D. Howanitz E. Parrella M. et al. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites Am J Psychiatry 155 1998 1080-1086
158. Harvey P.D. Parrella M. White L. Mohs R.C. Davidson M. Davis K.L. Convergence of cognitive and adaptive decline in late-life schizophrenia Schizophr Res 35 1999 77-84
159. Purohit D.P. Perl D.P. Haroutunian V. Powchik P. Davidson M. Davis K. Alzheimer's disease and related neurodegenerative diseases in elderly schizophrenic patients Arch Gen Psychiatry 55 1998 205-211
160. Rajkowska G. Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria Cereb Cortex 5 1995 307-322
161. Rajkowska G. Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the talairach coordinate system Cereb Cortex 5 1995 323-337
162. Mi L.J. Mak K.M. Lieber C.S. Attenuation of alcohol-induced apoptosis of hepatocytes in rat livers by polyenylphosphatidylcholine (PPC) Alcohol Clin Exp Res 24 2000 207-212
163. Meana J. Ibrahim H.M. Hogg A.J. Haroutunian V. Davis K.L. Watson S.J. Dysregulation of corticostriatal and thalamocortical glutamatergic circuitry in schizophrenic brain Collegium Internationale Neuro-Psychopharmacologicum Congress Abstract 1998
164. Meador-Woodruff JH, Healy DJ, Damask SP, et al. Ionotropic glutamate receptor mRNA expression in schizophrenia. International Congress on Schizophrenia Research; 1997.
165. Haroutunian V. Dracheva S. Elhakem S.L. Davis K.L. AMPA and kainate receptor expression in DLPFC and occipital cortices of elderly schizophrenia patients Biol Psychiatry 51 2002 110S
166. Vawter M.P. Barrett T. Cheadle C. et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia Brain Res Bull 55 2001 641-650
167. Frerking M. Malenka R.C. Nicoll R.A. Synaptic activation of kainate receptors on hippocampal interneurons Nat Neurosci 1 1998 479-486
168. Rodriguez-Moreno A. Herreras O. Lerma J. Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus Neuron 19 1997 893-901
169. Gluck M.R. Thomas R.G. Knott P.J. Davis K.L. Haroutunian V. Increased glutaminase activity is dorsolateral prefrontal cortex of aged schizophrenics: implications for altered glutamate metabolism in schizophrenia Soc Neurosci 2000
170. Bergles D.E. Roberts J.D. Somogyi P. Jahr C.E. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus Nature 405 2000 187-191
171. Matute C. Alberdi E. Domercq M. Perez-Cerda F. Perez-Samartin A. Sanchez-Gomez M.V. The link between excitotoxic oligodendroglial death and demyelinating diseases Trends Neurosci 24 2001 224-230